APOC1 and diffuse large B-cell lymphoma: Importantly, studies suggest that apolipoproteins can inhibit PI3K/AKT/mTOR-mediated angiogenesis in breast cancer [24], which supports the hypothesis that APOC1 may play a role in the malignant progression and angiogenesis of DLBCL via this signaling pathway.